Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Retina. 2022 Jul 1;42(7):1302–1310. doi: 10.1097/IAE.0000000000003479

Table 1.

Baseline participant characteristics among eyes with gradable UWF-FA images and color photographs

Participant Characteristics
(N = 361 participants)
Female, N (%) 183 (50.7)
Age (yr.), Median (IQR) 62 (53, 69)
Race/Ethnicity, N (%)
 White 242 (67.0)
 Black/African American 68 (18.8)
 Hispanic or Latino 33 (9.1)
 Asian 10 (2.8)
 Native Hawaiian/Other Pacific Islander 1 (0.3)
 More than one race 3 (0.8)
 Unknown/not reported 4 (1.1)
Diabetes type, N (%)
 Type 1 49 (13.6)
 Type 2 307 (85.0)
 Uncertain 5 (1.4)
Duration of diabetes (yr.), Median (IQR) 20 (13, 28)
HbA1c (%), Median (IQR) * 7.9 (7.0, 9.0)
Mean arterial pressure (mmHg), Median (IQR) 97 (90, 106)
Bilateral participant, N (%) 186 (51.5)
Ocular Characteristics
(N = 652 eyes)
Study eyes, N (%) 529 (81.1)
Visual acuity (letter score), Median (IQR) 85 (81, 89)
 ~Snellen equivalent, Median (IQR) 20/20 (20/25, 20/16)
DR severity assessed within the ETDRS 7-fields on UWF-color, N (%)
 DR Absent (Level 10/12) 3 (0.5)
 DR Questionable or Microaneurysms Only (Level 14/15/20) 4 (0.6)
 Mild NPDR (Level 35) 200 (30.7)
 Moderate NPDR (Level 43) 157 (24.1)
 Moderately Severe NPDR (Level 47) 91 (14.0)
 Severe and Very Severe NPDR (Level 53) 167 (25.6)
 Inactive PDR or Mild PDR (Level 60/61) 12 (1.8)
 Moderate PDR (Level 65) 12 (1.8)
 High-risk PDR (Level 71/75) 6 (0.9)
DME severity based on UWF-color, N (%)
 No DME 401 (61.5)
 Questionable DME 4 (0.6)
 Less than clinically significant macular edema 175 (26.8)
 Clinically significant macular edema 61 (9.4)
 Ungradable 11 (1.7)
OCT central subfield thickness (Stratus equivalent, μm), Median (IQR) 213 (195, 234)
Phakic lens status on clinical examination, N (%) 479 (73.5)
*

HbA1c unavailable for 6 participants

Central subfield thickness unavailable for 1 eye

IQR, interquartile range; DR, diabetic retinopathy; ETDRS, Early Treatment Diabetic Retinopathy Study; UWF, ultrawide field; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; DME, diabetic macular edema; OCT, optical coherence tomography.